Chikungunya Vaccine Candidate Induces Strong Immune Response

TUESDAY, June 13, 2023 -- The live attenuated vaccine candidate for active immunization and prevention of disease caused by chikungunya virus, VLA1553, induces a strong immune response and seroprotective titers in almost all vaccinated persons,...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news